Posted by Michael Wonder on 17 Mar 2026
PBAC advice on equitable access to GLP-1 obesity treatments
17 March 2026 - On 6 March 2025, Minister Butler wrote to the PBAC to request the Committee’s advice on equitable access to glucagon like peptide-1 (GLP-1) receptor agonists for obesity through the PBS. The PBAC provided advice on this matter at its November 2025 meeting.
The PBAC welcomed and considered input from individuals who have used GLP-1 receptor agonists, other individuals, health care professionals and organisations.
